Variable | All participants (n = 150) | Stimulants main drug (n = 72) | Opioids main drug (n = 56) | Stimulants and opioids main drug (n = 17) | p value | ||||
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | ||
Current treatment | |||||||||
None | 52 | 34.7 | 20 | 27.8 | 23 | 41.1 | 7 | 41.2 | .263 |
Methadone | 50 | 33.3 | 24 | 33.3 | 20 | 35.7 | 6 | 35.3 | .957 |
Buprenorphine/Suboxone | 37 | 24.7 | 24 | 33.3 | 9 | 16.1 | 1 | 5.9 | .016* |
Outpatient | 23 | 15.3 | 14 | 19.4 | 7 | 12.5 | 2 | 11.8 | .589 |
12-step/recovery group | 1 | 0.7 | 1 | 1.4 | 0 | 0.0 | 0 | 0.0 | .999 |
Past year treatment | |||||||||
None | 32 | 21.3 | 14 | 19.4 | 11 | 19.6 | 5 | 29.4 | .640 |
Methadone | 66 | 44.0 | 26 | 36.1 | 32 | 57.1 | 8 | 47.1 | .059 |
Buprenorphine/Suboxone | 50 | 33.3 | 29 | 40.3 | 13 | 23.2 | 5 | 29.4 | .119 |
Outpatient | 24 | 16.0 | 16 | 22.2 | 7 | 12.5 | 1 | 5.9 | .192 |
Inpatient | 15 | 10.0 | 6 | 8.3 | 6 | 10.7 | 3 | 17.6 | .502 |
12-step/recovery group | 2 | 1.3 | 2 | 2.8 | 0 | 0.0 | 0 | 0.0 | .614 |